$KALA
KALA BIO, Inc.

2020 Q4 Form 10-K Financial Statement

#000155837021001797 Filed on February 25, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4
Revenue $2.238M $6.362M $1.180M
YoY Change 89.66% 4.74%
Cost Of Revenue $1.360M $3.170M $750.0K
YoY Change 81.33% 57.71%
Gross Profit $880.0K $3.190M $430.0K
YoY Change 104.65% -21.62%
Gross Profit Margin 39.32% 50.14% 36.44%
Selling, General & Admin $26.47M $81.07M $14.49M
YoY Change 82.68% 24.69% 1.12%
% of Gross Profit 3007.95% 2541.32% 3369.77%
Research & Development $3.400M $18.35M $6.140M
YoY Change -44.63% -32.71% -33.55%
% of Gross Profit 386.36% 575.3% 1427.91%
Depreciation & Amortization $240.0K $912.0K $230.0K
YoY Change 4.35% 8.19% 109.09%
% of Gross Profit 27.27% 28.59% 53.49%
Operating Expenses $31.22M $102.6M $21.38M
YoY Change 46.05% 8.8% -9.3%
Operating Profit -$30.34M -$96.23M -$20.95M
YoY Change 44.85% 9.08%
Interest Expense -$2.130M $8.589M -$1.760M
YoY Change 21.02% 1.29% 39.68%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$31.11M -$104.3M -$21.96M
YoY Change 41.67% 10.58% -12.93%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$31.11M -$104.3M -$21.96M
YoY Change 41.67% 10.58% -12.93%
Net Earnings / Revenue -1390.08% -1639.85% -1861.02%
Basic Earnings Per Share -$1.99
Diluted Earnings Per Share -$546.2K -$1.99 -$629.0K
COMMON SHARES
Basic Shares Outstanding 56.08M 52.38M
Diluted Shares Outstanding 52.38M

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $153.5M $153.5M $85.40M
YoY Change 79.74% 79.74% -50.03%
Cash & Equivalents $77.26M $85.45M
Short-Term Investments $76.30M $76.30M
Other Short-Term Assets $3.000M $2.700M $3.800M
YoY Change -21.05% 17.39% 90.0%
Inventory $5.229M $5.200M $4.648M
Prepaid Expenses
Receivables $9.604M $9.600M $11.56M
Other Receivables $0.00 $300.0K $0.00
Total Short-Term Assets $171.4M $171.4M $105.5M
YoY Change 62.47% 62.46% -40.4%
LONG-TERM ASSETS
Property, Plant & Equipment $3.166M $31.00M $2.698M
YoY Change 17.35% -4.62% -91.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $19.20M $19.20M $16.40M
YoY Change 17.07% 17.07% 34.43%
Total Long-Term Assets $50.23M $50.20M $48.84M
YoY Change 2.84% 2.87% 11.0%
TOTAL ASSETS
Total Short-Term Assets $171.4M $171.4M $105.5M
Total Long-Term Assets $50.23M $50.20M $48.84M
Total Assets $221.6M $221.6M $154.3M
YoY Change 43.6% 43.62% -30.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.724M $1.700M $2.518M
YoY Change -31.53% -32.0% -53.37%
Accrued Expenses $18.97M $20.50M $20.93M
YoY Change -9.36% -8.07% 80.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.23M $22.20M $24.77M
YoY Change -10.29% -10.48% 45.73%
LONG-TERM LIABILITIES
Long-Term Debt $72.24M $72.20M $71.18M
YoY Change 1.49% 1.4% 1.4%
Other Long-Term Liabilities $27.10M $27.10M $28.70M
YoY Change -5.57% -5.57% -0.35%
Total Long-Term Liabilities $99.39M $99.30M $99.86M
YoY Change -0.47% -0.6% 0.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.23M $22.20M $24.77M
Total Long-Term Liabilities $99.39M $99.30M $99.86M
Total Liabilities $121.6M $121.6M $124.6M
YoY Change -2.42% -2.41% 7.44%
SHAREHOLDERS EQUITY
Retained Earnings -$399.8M -$295.5M
YoY Change 35.31%
Common Stock $59.00K $36.00K
YoY Change 63.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.0M $100.0M $29.69M
YoY Change
Total Liabilities & Shareholders Equity $221.6M $221.6M $154.3M
YoY Change 43.6% 43.62% -30.17%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4
OPERATING ACTIVITIES
Net Income -$31.11M -$104.3M -$21.96M
YoY Change 41.67% 10.58% -12.93%
Depreciation, Depletion And Amortization $240.0K $912.0K $230.0K
YoY Change 4.35% 8.19% 109.09%
Cash From Operating Activities -$25.91M -$90.69M -$18.21M
YoY Change 42.28% -2.19% 13.88%
INVESTING ACTIVITIES
Capital Expenditures -$480.0K -$1.940M -$190.0K
YoY Change 152.63% 44.78% -79.12%
Acquisitions
YoY Change
Other Investing Activities $37.32M -$76.27M
YoY Change
Cash From Investing Activities $36.84M -$78.21M -$190.0K
YoY Change -19489.47% 5758.35% -79.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $158.6M
YoY Change 1781.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.72M 160.6M 6.290M
YoY Change 229.41% 1688.33% -94.88%
NET CHANGE
Cash From Operating Activities -25.91M -90.69M -18.21M
Cash From Investing Activities 36.84M -78.21M -190.0K
Cash From Financing Activities 20.72M 160.6M 6.290M
Net Change In Cash 31.65M -8.275M -12.11M
YoY Change -361.35% -90.27% -111.42%
FREE CASH FLOW
Cash From Operating Activities -$25.91M -$90.69M -$18.21M
Capital Expenditures -$480.0K -$1.940M -$190.0K
Free Cash Flow -$25.43M -$88.75M -$18.02M
YoY Change 41.12% -2.87% 19.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001479419
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58915375
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36086254
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58915375
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36086254
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-38150
CY2020 dei Entity Registrant Name
EntityRegistrantName
KALA PHARMACEUTICALS, INC.
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-0604595
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
490 Arsenal Way, Suite 120
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
CY2020 dei City Area Code
CityAreaCode
781
CY2020 dei Local Phone Number
LocalPhoneNumber
996-5252
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2020 dei Trading Symbol
TradingSymbol
KALA
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
411800000
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61552352
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77264000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85449000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
76276000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9604000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11563000
CY2020Q4 us-gaap Inventory Net
InventoryNet
5229000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4648000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3006000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3824000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
171379000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
105484000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3166000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2698000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
6219000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3778000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27853000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29781000
CY2020Q4 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
12989000
CY2019Q4 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
12582000
CY2020Q4 us-gaap Assets
Assets
221606000
CY2019Q4 us-gaap Assets
Assets
154323000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1724000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2518000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18971000
CY2019Q4 us-gaap Liabilities
Liabilities
124631000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
99857000
CY2020Q4 us-gaap Liabilities
Liabilities
121611000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20929000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1530000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1327000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22225000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24774000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
27143000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
28673000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72243000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71184000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
99386000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58915375
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36086254
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
59000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
36000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
499715000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325112000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-399783000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-295456000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
99995000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29692000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221606000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154323000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6362000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6074000
CY2020 kala Product Revenue Cost
ProductRevenueCost
3173000
CY2019 kala Product Revenue Cost
ProductRevenueCost
2008000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
81068000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65015000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18352000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27275000
CY2020 us-gaap Operating Expenses
OperatingExpenses
102593000
CY2019 us-gaap Operating Expenses
OperatingExpenses
94298000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-96231000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-88224000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
493000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
2357000
CY2020 us-gaap Interest Expense
InterestExpense
8589000
CY2019 us-gaap Interest Expense
InterestExpense
8480000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-8096000
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-6123000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-104327000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-94347000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.99
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.76
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52377526
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34209756
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-104327000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-94347000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-104323000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94347000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
104978000
CY2019 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
262000
CY2019 kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
8425000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
42000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
545000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10049000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-94347000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29692000
CY2020 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
1026000
CY2020 kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
33134000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1087000
CY2020 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
8475000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
125423000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1016000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13966000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-104327000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
99995000
CY2020 us-gaap Profit Loss
ProfitLoss
-104327000
CY2019 us-gaap Profit Loss
ProfitLoss
-94347000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
912000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
843000
CY2020 kala Non Cash Operating Lease
NonCashOperatingLease
1928000
CY2019 kala Non Cash Operating Lease
NonCashOperatingLease
1773000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1059000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
958000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
13312000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9991000
CY2020 kala Amortization Of Discount On Available For Sale Securities
AmortizationOfDiscountOnAvailableForSaleSecurities
-5000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1959000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11563000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-818000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1789000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2368000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4271000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-924000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2770000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1763000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9630000
CY2020 kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-1295000
CY2019 kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-1175000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90694000
CY2020 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
37325000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78209000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1335000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
158557000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92720000
CY2020 kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
1942000
CY2019 kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
1335000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
113592000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8425000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
32000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
30000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2103000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
587000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
160628000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8982000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8275000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-85073000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98031000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
183104000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89756000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98031000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89756000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98031000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12492000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12582000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77264000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85449000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
136000
CY2020 kala Capital Expenditures Incurred But Not Yet Paid Accounts Payable
CapitalExpendituresIncurredButNotYetPaidAccountsPayable
130000
CY2019 kala Capital Expenditures Incurred But Not Yet Paid Accounts Payable
CapitalExpendituresIncurredButNotYetPaidAccountsPayable
195000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
7528000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
7522000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1852000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-104327000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-94347000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90694000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92720000
CY2020 kala Payment Typically Received Minimum
PaymentTypicallyReceivedMinimum
P70D
CY2020 kala Payment Typically Received Maximum
PaymentTypicallyReceivedMaximum
P90D
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<b style="font-weight:bold;">Use of Estimates—</b> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expense, and related disclosures. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. Estimates and assumptions relied upon in preparing these consolidated financial statements relate to, but are not limited to, revenue recognition, inventory, the present value of lease liabilities and the corresponding right-of-use assets, the fair value of warrants, stock-based compensation, accrued expenses and the recoverability of the Company’s net deferred tax assets and related valuation allowance. Actual results may differ from these estimates under different assumptions or conditions.
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Cash and Concentration of Credit Risk</b>—Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investments and accounts receivable. Periodically, the Company maintains cash, cash equivalents, short-term investments in accredited financial institutions in excess of federally insured limits. The Company deposits its cash, cash equivalents, short-term investments in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Three Customers comprised 10% or more of the Company’s accounts receivable balance as of December 31, 2020 and 2019. These Customers comprised 39%, 33% and 25% of the accounts receivable balance, respectively, as of December 31, 2020 and 41%, 35% and 23% of the accounts receivable balance, respectively, as of December 31, 2019. To date, the Company has not experienced any losses with respect to the collection of its accounts receivable and believes that its entire accounts receivable balances is collectible as of December 31, 2020. The same three Customers comprised 10% or more of the Company’s revenue during the years ended December 31, 2020 and 2019. These Customers comprised 40%, 29% and 28% of revenue, respectively, during the year ended December 31, 2020 and 39%, 33% and 26% of revenue, respectively, during the year ended December 31, 2019. The Company has no financial instruments with off-balance sheet risk of loss.</p>
CY2020 kala Number Of Counter Parties
NumberOfCounterParties
3
CY2020 kala Number Of Counter Parties
NumberOfCounterParties
3
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12492000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12582000
CY2019 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
6219000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4648000
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
0
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
76272000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
76276000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
801000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1387000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6437000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4166000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4210000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2873000
CY2020Q4 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
11448000
CY2019Q4 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
8426000
CY2020Q4 us-gaap Inventory Net
InventoryNet
5229000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3778000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1201000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
906000
CY2020Q4 kala Prepaid Deposits
PrepaidDeposits
606000
CY2019Q4 kala Prepaid Deposits
PrepaidDeposits
699000
CY2020Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
250000
CY2019Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
1535000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
949000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
684000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3006000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3824000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6590000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5214000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3424000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2516000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3166000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2698000
CY2020 us-gaap Depreciation
Depreciation
908000
CY2019 us-gaap Depreciation
Depreciation
843000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9676000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6502000
CY2020Q4 kala Accrued Revenue Reserves
AccruedRevenueReserves
5224000
CY2019Q4 kala Accrued Revenue Reserves
AccruedRevenueReserves
9482000
CY2020Q4 kala Accrued Commercialization Cost
AccruedCommercializationCost
2103000
CY2019Q4 kala Accrued Commercialization Cost
AccruedCommercializationCost
930000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
760000
CY2020Q4 kala Accrued Contract Manufacturing
AccruedContractManufacturing
336000
CY2019Q4 kala Accrued Contract Manufacturing
AccruedContractManufacturing
630000
CY2020Q4 kala Development Costs Current
DevelopmentCostsCurrent
154000
CY2019Q4 kala Development Costs Current
DevelopmentCostsCurrent
1600000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
552000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1025000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18971000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20929000
CY2019Q4 kala Number Of Vehicles Leased
NumberOfVehiclesLeased
65
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
450000
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
450000
CY2019Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2020 kala Lessee Operating Lease Remaining Term Of Contract
LesseeOperatingLeaseRemainingTermOfContract
P1Y2M12D
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
4741000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
4614000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
1848000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
1766000
CY2020 us-gaap Lease Cost
LeaseCost
6589000
CY2019 us-gaap Lease Cost
LeaseCost
6380000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
5981000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
5445000
CY2018Q4 kala Debt Instrument Number Of Features Comprising Embedded Derivative
DebtInstrumentNumberOfFeaturesComprisingEmbeddedDerivative
2
CY2018Q4 us-gaap Derivative Liability Number Of Instruments Held
DerivativeLiabilityNumberOfInstrumentsHeld
1
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
10000000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
10000000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
16665000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
33330000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
25005000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
75000000
CY2020 kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
248505
CY2019 kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
297988
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58915375
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36086254
CY2020 kala Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2020 kala Number Of Directors Granted Per Voting Block Of Outstanding Shares
NumberOfDirectorsGrantedPerVotingBlockOfOutstandingShares
1
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11744473
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8488405
CY2020 kala Share Based Compensation Arrangement By Share Based Payment Award Award Anniversary
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardAnniversary
P1Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.796
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.825
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.807
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.837
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0037
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0173
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0144
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0258
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.20
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.45
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2124000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
98000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13312000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9991000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1087000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
42000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
942222
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.70
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.222
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.258
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.009
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.010
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.012
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.043
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.009
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
67368000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
49018000
CY2020Q4 kala Deferred Tax Assets Tax Deferred Lease Liabilities
DeferredTaxAssetsTaxDeferredLeaseLiabilities
8152000
CY2019Q4 kala Deferred Tax Assets Tax Deferred Lease Liabilities
DeferredTaxAssetsTaxDeferredLeaseLiabilities
9369000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
7413000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
5414000
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
5258000
CY2019Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
6733000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2398000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6250000
CY2020Q4 kala Deferred Tax Assets Tax Deferred Expense Rebates Incentives Trade Discounts And Allowances
DeferredTaxAssetsTaxDeferredExpenseRebatesIncentivesTradeDiscountsAndAllowances
2177000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
2609000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
2467000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
95375000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
79251000
CY2020Q4 kala Operating Or Finance Lease Right Of Use Asset
OperatingOrFinanceLeaseRightOfUseAsset
7810000
CY2019Q4 kala Operating Or Finance Lease Right Of Use Asset
OperatingOrFinanceLeaseRightOfUseAsset
9178000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7810000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
9178000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
87565000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
70073000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17492000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2398000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6250000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020 kala Annual Minimum Payment Of License Fee
AnnualMinimumPaymentOfLicenseFee
38000
CY2020 kala Annual Minimum Payment Of License Fee If Company Achieves First Commercial Sale
AnnualMinimumPaymentOfLicenseFeeIfCompanyAchievesFirstCommercialSale
113000
CY2020Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
113000
CY2020Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
113000
CY2020Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
113000
CY2020Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
113000
CY2020Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
113000
CY2020Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
900000
CY2020Q4 us-gaap Contractual Obligation
ContractualObligation
1465000
CY2020 kala Purchase Obligations Fiscal Year Maturity Schedule Table Textblock
PurchaseObligationsFiscalYearMaturityScheduleTableTextblock
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has the following minimum purchase obligations for EYSUVIS and INVELTYS:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Years Ending December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">2,295 </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">5,390 </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">6,285 </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">7,875 </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2025</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">8,199 </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">17,925 </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Total minimum purchase commitments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">47,969 </p></td></tr></table>
CY2020Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
2295000
CY2020Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
5390000
CY2020Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
6285000
CY2020Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
7875000
CY2020Q4 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
8199000
CY2020Q4 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
17925000
CY2020Q4 us-gaap Purchase Obligation
PurchaseObligation
47969000
CY2019Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2020Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
446000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
454000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1071000
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
833000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2220000
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2238000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
21196000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
22113000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
28062000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
31222000
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1830000
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2032000
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2106000
CY2020Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2128000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21955000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23312000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27948000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31112000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1386000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2057000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1451000
CY2019Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1761000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25388000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23825000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23176000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21958000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1180000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
25436000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
24467000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
23018000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
21377000
CY2019Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1338000
CY2019Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1415000
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1609000

Files In Submission

Name View Source Status
0001558370-21-001797-index-headers.html Edgar Link pending
0001558370-21-001797-index.html Edgar Link pending
0001558370-21-001797.txt Edgar Link pending
0001558370-21-001797-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kala-20201231.xsd Edgar Link pending
kala-20201231x10k.htm Edgar Link pending
kala-20201231x10k006.jpg Edgar Link pending
kala-20201231x10k007.jpg Edgar Link pending
kala-20201231x10k009.jpg Edgar Link pending
kala-20201231x10k011.jpg Edgar Link pending
kala-20201231x10k012.jpg Edgar Link pending
kala-20201231x10k013.jpg Edgar Link pending
kala-20201231x10k014.jpg Edgar Link pending
kala-20201231x10k_htm.xml Edgar Link completed
kala-20201231xex10d26.htm Edgar Link pending
kala-20201231xex10d26001.jpg Edgar Link pending
kala-20201231xex10d31.htm Edgar Link pending
kala-20201231xex21d1.htm Edgar Link pending
kala-20201231xex23d1.htm Edgar Link pending
kala-20201231xex31d1.htm Edgar Link pending
kala-20201231xex31d2.htm Edgar Link pending
kala-20201231xex32d1.htm Edgar Link pending
kala-20201231xex32d2.htm Edgar Link pending
kala-20201231xex4d2.htm Edgar Link pending
kala-20201231_cal.xml Edgar Link unprocessable
kala-20201231_def.xml Edgar Link unprocessable
kala-20201231_lab.xml Edgar Link unprocessable
kala-20201231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending